7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.1038/254635a0
Copy DOIJournal: Nature | Publication Date: Apr 1, 1975 |
Citations: 62 |
BRADYKININ is a vasoactive nonapeptide believed to mediate various acute inflammatory conditions1. Although its production in plasma is well defined1, an understanding of its role in disease is hampered by the lack of information about the mechanism by which it can be generated by an immune process or by any stimulus other than clotting. Immune release of a kinin-generating factor from perfused sensitised guinea pig lung has been reported2,3. The release is not, however, calcium-dependent and the factor may be a product not of the primary allergic reaction, but of a secondary event4. Substantial information is available, however, about the release of other mediators of inflammatory or allergic reactions—histamine, SRS-A, and ECF-A5. These are secreted after antigen challenge of basophils and mast cells sensitised with IgE antibody6–7. The release depends on calcium and temperature, requires energy and is controlled by hormone-receptor interactions which influence the intracellular level of cyclic nucleotides10–13. We have now demonstrated the immune release of an enzyme from human leukocytes that hydrolyses p-toluene sulphonyl-L-arginine methyl ester (TAMe) and generates bradykinin from citrated human plasma. The release is initiated by the interaction of antigen or anti-IgE with cell-bound IgE6,14 and seems to be similar in mechanism to the release of histamine and the other mediators of the allergic response.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.